Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Fuji
Federal Trade Commission
McKesson
US Department of Justice
Covington

Generated: March 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tremelimumab

« Back to Dashboard

US Patents for Tremelimumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tremelimumab ➤ Try a Free Trial Immunoregulatory agents Flexus Biosciences, Inc. (Princeton, NJ) ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial .beta.-glucan methods and compositions that affect the tumor microenvironment BIOTHERA, INC. (Eagan, MN) ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial Methods of using OX40 ligand encoding polynucleotides ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial Intralesional (Intratumoral) dinitrochlorobenzene and associated compounds coadministered with checkpoint inhibitors for cancer treatment including treatment of metastatic cutaneous cancers ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial Combinations of mRNAs encoding immune modulating polypeptides and uses thereof ModernaTX, Inc. (Cambridge, MA) ➤ Try a Free Trial
Tremelimumab ➤ Try a Free Trial Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors Immunomedics, Inc. (Morris Plains, NJ) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Tremelimumab

Drugname Country Document Number Estimated Expiration Related US Patent
Tremelimumab Argentina 102536 2034-11-05 ➤ Try a Free Trial
Tremelimumab Australia 2015342940 2034-11-05 ➤ Try a Free Trial
Tremelimumab Brazil 112017008568 2034-11-05 ➤ Try a Free Trial
Tremelimumab Canada 2964290 2034-11-05 ➤ Try a Free Trial
Tremelimumab Chile 2017001124 2034-11-05 ➤ Try a Free Trial
Tremelimumab China 107427499 2034-11-05 ➤ Try a Free Trial
Tremelimumab Eurasian Patent Organization 201790992 2034-11-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Julphar
Covington
QuintilesIMS
Cantor Fitzgerald
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.